|Day's Range||45.05 - 45.20|
|52 Week Range||29.95 - 58.95|
|PE Ratio (TTM)||-31.37|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The quest has seemed so elusive that it regularly draws comparison to the Holy Grail and unicorns.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Pacira Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PCRX-US. Comparing the performance and risk of Pacira Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
Categories: Yahoo FinanceGet free summary analysis Pacira Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Pacira Pharmaceuticals, Inc. – DURECT Corporation, Acura Pharmaceuticals, Inc., Recro Pharma, Inc., Heron Therapeutics Inc, BioDelivery Sciences International, Inc., Cara Therapeutics Inc, Flexion Therapeutics, Inc., Cumberland Pharmaceuticals Inc., ... Read more (Read more...)